Warning: The NCBI web site requires JavaScript to function. more...
Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement.
Trysberg E, Blennow K, Zachrisson O, Tarkowski A.
Arthritis Res Ther. 2004;6(6):R551-6. Epub 2004 Sep 23.
Related citations
Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement.
Trysberg E, Nylen K, Rosengren LE, Tarkowski A.
Arthritis Rheum. 2003 Oct;48(10):2881-7.
Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement.
Trysberg E, Carlsten H, Tarkowski A.
Lupus. 2000;9(7):498-503.
Decreased levels of soluble amyloid beta-protein precursor and beta-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus.
Trysberg E, Höglund K, Svenungsson E, Blennow K, Tarkowski A.
Arthritis Res Ther. 2004;6(2):R129-36. Epub 2004 Jan 22.
Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
Ainiala H, Hietaharju A, Dastidar P, Loukkola J, Lehtimäki T, Peltola J, Korpela M, Heinonen T, Nikkari ST.
Arthritis Rheum. 2004 Mar;50(3):858-65.
Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
Kwieciński J, Kłak M, Trysberg E, Blennow K, Tarkowski A, Jin T.
Arthritis Rheum. 2009 Jul;60(7):2094-101.
Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms.
George-Chandy A, Trysberg E, Eriksson K.
Arthritis Res Ther. 2008;10(4):R97. Epub 2008 Aug 22.
Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases.
Liuzzi GM, Mastroianni CM, Santacroce MP, Fanelli M, D'Agostino C, Vullo V, Riccio P.
J Neurovirol. 2000 Apr;6(2):156-63.
Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement.
Hirohata S, Miyamoto T.
Arthritis Rheum. 1990 May;33(5):644-9.
Prolactin and interleukin-6 in neuropsychiatric lupus erythematosus.
Jara LJ, Irigoyen L, Ortiz MJ, Zazueta B, Bravo G, Espinoza LR.
Clin Rheumatol. 1998;17(2):110-4.
Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis.
Matsuura E, Umehara F, Hashiguchi T, Fujimoto N, Okada Y, Osame M.
J Neurol Sci. 2000 Feb 1;173(1):45-52.
Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus.
Isshi K, Hirohata S.
Arthritis Rheum. 1998 Oct;41(10):1819-27.
Activity of matrix metalloproteinase-9 is elevated in sera of patients with systemic lupus erythematosus.
Faber-Elmann A, Sthoeger Z, Tcherniack A, Dayan M, Mozes E.
Clin Exp Immunol. 2002 Feb;127(2):393-8.
The study of anticardiolipin antibodies and interleukin-6 in cerebrospinal fluid and blood of Chinese patients with systemic lupus erythematosus and central nervous system involvement.
Yeh TS, Wang CR, Jeng GW, Lee GL, Chen MY, Wang GR, Lin KT, Chuang CY, Chen CY.
Autoimmunity. 1994;18(3):169-75.
Persistent increase of matrix metalloproteinases in cerebrospinal fluid of tuberculous meningitis.
Lee KY, Kim EH, Yang WS, Ryu H, Cho SN, Lee BI, Heo JH.
J Neurol Sci. 2004 May 15;220(1-2):73-8.
Elevated circulatory MMP-2 and MMP-9 levels and activities in patients with rheumatoid arthritis and systemic lupus erythematosus.
Chang YH, Lin IL, Tsay GJ, Yang SC, Yang TP, Ho KT, Hsu TC, Shiau MY.
Clin Biochem. 2008 Aug;41(12):955-9. Epub 2008 Apr 26.
Cerebrospinal fluid interleukin-6, prostaglandin E2 and autoantibodies in patients with neuropsychiatric systemic lupus erythematosus and central nervous system infections.
Tsai CY, Wu TH, Tsai ST, Chen KH, Thajeb P, Lin WM, Yu HS, Yu CL.
Scand J Rheumatol. 1994;23(2):57-63.
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis.
Fainardi E, Castellazzi M, Bellini T, Manfrinato MC, Baldi E, Casetta I, Paolino E, Granieri E, Dallocchio F.
Mult Scler. 2006 Jun;12(3):294-301.
Investigation of cytokine (tumor necrosis factor-alpha, interleukin-6, interleukin-10) concentrations in the cerebrospinal fluid of female patients with multiple sclerosis and systemic lupus erythematosus.
Baraczka K, Nékám K, Pozsonyi T, Szüts I, Ormos G.
Eur J Neurol. 2004 Jan;11(1):37-42.
Interleukin-1 and interleukin-6 activities are increased in the cerebrospinal fluid of patients with CNS lupus erythematosus and correlate with local late T-cell activation markers.
Alcocer-Varela J, Aleman-Hoey D, Alarcon-Segovia D.
Lupus. 1992 Feb;1(2):111-7.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on